Cited by 32Telemedicine and Telehealth ImplementationCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies

Association of a remote patient monitoring (RPM) program with reduced hospitalizations in cancer patients with COVID-19

Open access
Pritchett, Joshua C., Borah, Bijan J., Desai, Aakash P., Xie, Zhuoer, Saliba, Antoine N., Leventakos, Konstantinos, Coffey, Jordan D., Pearson, Kristina K. +7 more·2021·JCO Oncology Practice

Abstract

PURPOSE: The goal of this study was to assess the impact of an interdisciplinary remote patient monitoring (RPM) program on clinical outcomes and acute care utilization in cancer patients with COVID-19. METHODS: This is a cross-sectional analysis following a prospective observational study performed at Mayo Clinic Cancer Center. Adult patients receiving cancer-directed therapy or in recent remission on active surveillance with polymerase chain reaction–confirmed SARS-CoV-2 infection between March 18 and July 31, 2020, were included. RPM was composed of in-home technology to assess symptoms and physiologic data with centralized nursing and physician oversight. RESULTS: During the study timeframe, 224 patients with cancer were diagnosed with COVID-19. Of the 187 patients (83%) initially managed in the outpatient setting, those who did not receive RPM were significantly more likely to experience hospitalization than those receiving RPM. Following balancing of patient characteristics by inverse propensity score weighting, rates of hospitalization for RPM and non-RPM patients were 2.8% and 13%, respectively, implying that the use of RPM was associated with a 78% relative risk reduction in hospital admission rate (95% CI, 54 to 102; P = .002). Furthermore, when hospitalized, these patients experienced a shorter length of stay and fewer prolonged hospitalizations, intensive care unit admissions, and deaths, although these trends did not reach statistical significance. CONCLUSION: The use of RPM and a centralized virtual care team was associated with a reduction in hospital admission rate and lower overall acute care resource utilization among cancer patients with COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/op.21.00307

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pritchett, J. C., Borah, B. J., Desai, A. P., Xie, Z., Saliba, A. N., Leventakos, K., Coffey, J. D., Pearson, K. K., Speicher, L. L., Orenstein, R., Virk, A., Ganesh, R., Paludo, J., Halfdanarson, T. R., & Haddad, T. C.
Affiliations
Novartis (Switzerland) (CH)
Corresponding author
Haddad, Tufia C.
Venue
JCO Oncology Practice
Published
2021-09
Volume
17
Issue
9
Pages
e1293-e1302
ISSN
  • 2688-1527 (ISSN-L)
  • 2688-1535
OpenAlex
W3164662413
Cited by
32
References
48
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 1
FWCI
5.19
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • JCO Oncology Practice (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Mayo Clinic
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
remote patient monitoring, COVID-19 pandemic, cancer patients, hospitalization, acute care utilization, length of hospital stay, intensive care unit admission, mortality
MeSH terms
COVID-19, SARS-CoV-2, Adult, Cross-Sectional Studies, Hospitalization, Humans, Monitoring, Physiologic, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review